Ivan Hyep
Chief Financial Officer · Bicara Therapeutics Inc.
- 2025
- Aug 12, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ivan Hyep files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Claire Mazumdar - $3.59M in BCAX purchases and sales in the last 12 months
- Ryan Cohlhepp - $3.46M in BCAX purchases and sales in the last 12 months
- David Raben - $741K in BCAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ivan Hyep?
Ivan Hyep is a corporate insider, tracked as Chief Financial Officer of Bicara Therapeutics Inc. (BCAX). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ivan Hyep submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ivan Hyep been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($3.07M) across all tracked filings.
